Skip Navigation

Ann H. Partridge, MD, MPH


Medical Oncology

Make an Appointment
Watch Video

Physician

  • Founder and Director, Program for Young Women with Breast Cancer
  • Director, Adult Survivorship Program
  • Senior Physician
  • Professor of Medicine, Harvard Medical School

Clinical Interests

  • Breast cancer in young women

Diseases Treated

Contact Information

  • Appointments617-632-2175 (new)
    617-632-3800 (follow-up)
  • Office Phone Number617-632-3800
  • Fax617-632-1930

Bio

Dr. Partridge received her MD from Cornell University Medical College in 1995. She completed her residency in internal medicine at the Hospital of the University of Pennsylvania and went on to complete fellowships in medical oncology and hematology at DFCI. Later she received an MPH from Harvard School of Public Health. She is a medical oncologist focusing on the care of women with breast cancer, and she has a particular interest in the psychosocial, behavioral, and communication issues in breast cancer care and treatment.

Board Certification:

  • Hematology, 2001
  • Internal Medicine, 1998
  • Medical Oncology, 2001

Fellowship:

  • Dana-Farber/Partners CancerCare, Hematology/Oncology

Residency:

  • University of Pennsylvania School of Medicine, Internal Medicine

Medical School:

  • Weill Medical College of Cornell University

Research

Clinical and Epidemiologic Research in Breast Cancer

Breast cancer is the most common malignancy in U.S. women, with over 215,000 new cases diagnosed in 2005. Although the median age at breast cancer diagnosis is approximately 65, more than 14,000 women 40 years of age or younger are diagnosed with breast cancer each year in the United States. Because women in this younger age group represent a minority of the women diagnosed with breast cancer, far less is known about breast cancer in younger women than older women. Evidence shows that young age is an independent risk factor for disease recurrence and death. It is controversial whether the poorer prognosis is a reflection of delays in diagnosis or differences in biology, but accumulating evidence indicates that biologic differences may play an important role. In addition to being at higher risk of dying from breast cancer than older women, young women with breast cancer are at increased risk of psychosocial distress at diagnosis and in follow-up when compared with older women. Young women with breast cancer face a variety of unique medical and psychosocial concerns as a result of their diagnosis and subsequent treatment. In particular, fertility and family planning, menopausal symptoms, and sexual functioning are of great concern to this patient population. Our research focuses on the psychosocial, behavioral, and communication issues associated with breast cancer care, especially the unique issues facing young women with breast cancer. Several ongoing projects include evaluation of adherence with hormonal therapies in women with early-stage breast cancer, assessment of fertility and fertility concerns in young women undergoing breast cancer treatment, and communication of study results to patients following clinical trial participation.

Lambertini M, Partridge AH, Del Mastro L. Reply to V. Turan et al. J Clin Oncol. 2018 Nov 08; JCO1800630.
View in: PubMed

Partridge AH. Pregnancy after cancer: Timing is everything. Cancer. 2018 Nov 15; 124(22):4290-4291.
View in: PubMed

Moore HCF, Unger JM, Phillips KA, Boyle F, Hitre E, Moseley A, Porter DJ, Francis PA, Goldstein LJ, Gomez HL, Vallejos CS, Partridge AH, Dakhil SR, Garcia AA, Gralow JR, Lombard JM, Forbes JF, Martino S, Barlow WE, Fabian CJ, Minasian LM, Meyskens FL, Gelber RD, Hortobagyi GN, Albain KS. Final Analysis of the Prevention of Early Menopause Study (POEMS)/SWOG Intergroup S0230. J Natl Cancer Inst. 2018 Oct 27.
View in: PubMed

Cottreau CM, Dashevsky I, Andrade SE, Li DK, Nekhlyudov L, Raebel MA, Ritzwoller DP, Partridge AH, Pawloski PA, Toh S. Pregnancy-Associated Cancer: A U.S. Population-Based Study. J Womens Health (Larchmt). 2018 Oct 10.
View in: PubMed

Zhou ES, Hall KT, Michaud AL, Blackmon JE, Partridge AH, Recklitis CJ. Open-label placebo reduces fatigue in cancer survivors: a randomized trial. Support Care Cancer. 2018 Oct 10.
View in: PubMed

Curigliano G, Burstein HJ, Winer EP, Gnant M, Dubsky P, Loibl S, Colleoni M, Regan MM, Piccart-Gebhart M, Senn HJ, Thürlimann B, André F, Baselga J, Bergh J, Bonnefoi H, Brucker SY, Cardoso F, Carey L, Ciruelos E, Cuzick J, Denkert C, Di Leo A, Ejlertsen B, Francis P, Galimberti V, Garber J, Gulluoglu B, Goodwin P, Harbeck N, Hayes DF, Huang CS, Huober J, Khaled H, Jassem J, Jiang Z, Karlsson P, Morrow M, Orecchia R, Osborne KC, Pagani O, Partridge AH, Pritchard K, Ro J, Rutgers EJT, Sedlmayer F, Semiglazov V, Shao Z, Smith I, Toi M, Tutt A, Viale G, Watanabe T, Whelan TJ, Xu B. De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017. Ann Oncol. 2018 Oct 01; 29(10):2153.
View in: PubMed

Cathcart-Rake EJ, Ruddy KJ, Gupta R, Kremers W, Gast K, Su HI, Partridge AH, Stewart EA, Liu H, He Y, Yang P. Amenorrhea after lung cancer treatment. Menopause. 2018 Aug 27.
View in: PubMed

Lambertini M, Di Maio M, Pagani O, Curigliano G, Poggio F, Del Mastro L, Paluch-Shimon S, Loibl S, Partridge AH, Demeestere I, Azim HA, Peccatori FA. The BCY3/BCC 2017 survey on physicians' knowledge, attitudes and practice towards fertility and pregnancy-related issues in young breast cancer patients. Breast. 2018 Aug 22; 42:41-49.
View in: PubMed

Faubion SS, Larkin LC, Stuenkel CA, Bachmann GA, Chism LA, Kagan R, Kaunitz AM, Krychman ML, Parish SJ, Partridge AH, Pinkerton JV, Rowen TS, Shapiro M, Simon JA, Goldfarb SB, Kingsberg SA. Management of genitourinary syndrome of menopause in women with or at high risk for breast cancer: consensus recommendations from The North American Menopause Society and The International Society for the Study of Women's Sexual Health. Menopause. 2018 Jun; 25(6):596-608.
View in: PubMed

Denduluri N, Chavez-MacGregor M, Telli ML, Eisen A, Graff SL, Hassett MJ, Holloway JN, Hurria A, King TA, Lyman GH, Partridge AH, Somerfield MR, Trudeau ME, Wolff AC, Giordano SH. Selection of Optimal Adjuvant Chemotherapy and Targeted Therapy for Early Breast Cancer: ASCO Clinical Practice Guideline Focused Update. J Clin Oncol. 2018 Aug 10; 36(23):2433-2443.
View in: PubMed

Hubbeling HG, Rosenberg SM, González-Robledo MC, Cohn JG, Villarreal-Garza C, Partridge AH, Knaul FM. Psychosocial needs of young breast cancer survivors in Mexico City, Mexico. PLoS One. 2018; 13(5):e0197931.
View in: PubMed

Lambertini M, Moore HCF, Leonard RCF, Loibl S, Munster P, Bruzzone M, Boni L, Unger JM, Anderson RA, Mehta K, Minton S, Poggio F, Albain KS, Adamson DJA, Gerber B, Cripps A, Bertelli G, Seiler S, Ceppi M, Partridge AH, Del Mastro L. Gonadotropin-Releasing Hormone Agonists During Chemotherapy for Preservation of Ovarian Function and Fertility in Premenopausal Patients With Early Breast Cancer: A Systematic Review and Meta-Analysis of Individual Patient-Level Data. J Clin Oncol. 2018 Jul 01; 36(19):1981-1990.
View in: PubMed

Poorvu PD, Partridge AH. Counterpoint: LHRH Agonists vs Ovarian Ablation for Suppression of Ovarian Function in Premenopausal Breast Cancer Patients. Ovarian Ablation Is a Viable Option for Select Patients. Oncology (Williston Park). 2018 04 15; 32(4):168, 171, 179.
View in: PubMed

Rosenberg SM, Greaney ML, Patenaude AF, Sepucha KR, Meyer ME, Partridge AH. "I don't want to take chances.": A qualitative exploration of surgical decision making in young breast cancer survivors. Psychooncology. 2018 Jun; 27(6):1524-1529.
View in: PubMed

Oktay K, Harvey BE, Partridge AH, Quinn GP, Reinecke J, Taylor HS, Wallace WH, Wang ET, Loren AW. Fertility Preservation in Patients With Cancer: ASCO Clinical Practice Guideline Update. J Clin Oncol. 2018 Jul 01; 36(19):1994-2001.
View in: PubMed

Gajra A, McCall L, Muss HB, Cohen HJ, Jatoi A, Ballman KV, Partridge AH, Sutton L, Parker BA, Magrinat G, Klepin HD, Lafky JM, Hurria A. The preference to receive chemotherapy and cancer-related outcomes in older adults with breast cancer CALGB 49907 (Alliance). J Geriatr Oncol. 2018 May; 9(3):221-227.
View in: PubMed

Park EM, Gelber S, Rosenberg SM, Seah DSE, Schapira L, Come SE, Partridge AH. Anxiety and Depression in Young Women With Metastatic Breast Cancer: A Cross-Sectional Study. Psychosomatics. 2018 May - Jun; 59(3):251-258.
View in: PubMed

Vaz-Luis I, Partridge AH. Exogenous reproductive hormone use in breast cancer survivors and previvors. Nat Rev Clin Oncol. 2018 Apr; 15(4):249-261.
View in: PubMed

Motwani SS, McMahon GM, Humphreys BD, Partridge AH, Waikar SS, Curhan GC. Development and Validation of a Risk Prediction Model for Acute Kidney Injury After the First Course of Cisplatin. J Clin Oncol. 2018 Mar 01; 36(7):682-688.
View in: PubMed

Stover DG, Parsons HA, Ha G, Freeman SS, Barry WT, Guo H, Choudhury AD, Gydush G, Reed SC, Rhoades J, Rotem D, Hughes ME, Dillon DA, Partridge AH, Wagle N, Krop IE, Getz G, Golub TR, Love JC, Winer EP, Tolaney SM, Lin NU, Adalsteinsson VA. Association of Cell-Free DNA Tumor Fraction and Somatic Copy Number Alterations With Survival in Metastatic Triple-Negative Breast Cancer. J Clin Oncol. 2018 Feb 20; 36(6):543-553.
View in: PubMed

Dubsky P, Curigliano G, Burstein HJ, Winer EP, Gnant M, Loibl S, Colleoni M, Regan MM, Piccart-Gebhart M, Senn HJ, Thürlimann B, André F, Baselga J, Bergh J, Bonnefoi H, Brucker SY, Cardoso F, Carey L, Ciruelos E, Cuzick J, Denkert C, Di Leo A, Ejlertsen B, Francis P, Galimberti V, Garber J, Gulluoglu B, Goodwin P, Harbeck N, Hayes DF, Huang CS, Huober J, Khaled H, Jassem J, Jiang Z, Karlsson P, Morrow M, Orecchia R, Osborne KC, Pagani O, Partridge AH, Pritchard K, Ro J, Rutgers EJT, Sedlmayer F, Semiglazov V, Shao Z, Smith I, Toi M, Tutt A, Viale G, Watanabe T, Whelan TJ, Xu B. Reply to 'The St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2017: the point of view of an International Panel of Experts in Radiation Oncology' by Kirova et al. Ann Oncol. 2018 Jan 01; 29(1):281-282.
View in: PubMed

Brown JC, Yung RL, Gobbie-Hurder A, Shockro L, O'Connor K, Campbell N, Kasper J, Mayer EL, Tolaney SM, Partridge AH, Ligibel JA. Randomized trial of a clinic-based weight loss intervention in cancer survivors. J Cancer Surviv. 2018 Apr; 12(2):186-195.
View in: PubMed

Rosenberg SM, Ligibel JA, Meyerhardt JA, Jacobsen ED, Garber JE, Nekhlyudov L, Bunnell CA, Nutting P, Sprunck-Harrild K, Walsh SK, Partridge AH. Developing a Novel Model to Improve Research and care for Cancer Survivors: a Feasibility Study. J Cancer Educ. 2017 Oct 20.
View in: PubMed

Paluch-Shimon S, Pagani O, Partridge AH, Abulkhair O, Cardoso MJ, Dent RA, Gelmon K, Gentilini O, Harbeck N, Margulies A, Meirow D, Pruneri G, Senkus E, Spanic T, Sutliff M, Travado L, Peccatori F, Cardoso F. ESO-ESMO 3rd international consensus guidelines for breast cancer in young women (BCY3). Breast. 2017 Oct; 35:203-217.
View in: PubMed

Grimm LJ, Ryser MD, Partridge AH, Thompson AM, Thomas JS, Wesseling J, Hwang ES. Surgical Upstaging Rates for Vacuum Assisted Biopsy Proven DCIS: Implications for Active Surveillance Trials. Ann Surg Oncol. 2017 Nov; 24(12):3534-3540.
View in: PubMed

Curigliano G, Burstein HJ, P Winer E, Gnant M, Dubsky P, Loibl S, Colleoni M, Regan MM, Piccart-Gebhart M, Senn HJ, Thürlimann B, André F, Baselga J, Bergh J, Bonnefoi H, Y Brucker S, Cardoso F, Carey L, Ciruelos E, Cuzick J, Denkert C, Di Leo A, Ejlertsen B, Francis P, Galimberti V, Garber J, Gulluoglu B, Goodwin P, Harbeck N, Hayes DF, Huang CS, Huober J, Hussein K, Jassem J, Jiang Z, Karlsson P, Morrow M, Orecchia R, Osborne KC, Pagani O, Partridge AH, Pritchard K, Ro J, Rutgers EJT, Sedlmayer F, Semiglazov V, Shao Z, Smith I, Toi M, Tutt A, Viale G, Watanabe T, Whelan TJ, Xu B. De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017. Ann Oncol. 2017 Aug 01; 28(8):1700-1712.
View in: PubMed

Partridge AH. Risk communication and decision-making in the prevention of invasive breast cancer. Breast. 2017 Aug; 34 Suppl 1:S55-S57.
View in: PubMed

Rosenberg SM, Gelber S, Gelber RD, Krop E, Korde LA, Pagani O, Partridge AH. Oncology Physicians' Perspectives on Practices and Barriers to Fertility Preservation and the Feasibility of a Prospective Study of Pregnancy After Breast Cancer. J Adolesc Young Adult Oncol. 2017 Sep; 6(3):429-434.
View in: PubMed

Poorvu PD, Partridge AH. Ovarian Suppression for Women Younger Than 35 Years: New Data to Support Informed Decision Making. J Clin Oncol. 2017 Sep 20; 35(27):3092-3094.
View in: PubMed

Partridge AH, Sepucha K, O'Neill A, Miller KD, Baker E, Dang CT, Northfelt DW, Sledge GW, Schneider BP. Does biomarker information impact breast cancer patients' preferences and physician recommendation for adjuvant chemotherapy? Breast Cancer Res Treat. 2017 Oct; 165(3):545-553.
View in: PubMed

Freedman RA, Partridge AH. Emerging Data and Current Challenges for Young, Old, Obese, or Male Patients with Breast Cancer. Clin Cancer Res. 2017 Jun 01; 23(11):2647-2654.
View in: PubMed

Partridge AH, Carey LA. Unmet Needs in Clinical Research in Breast Cancer: Where Do We Need to Go? Clin Cancer Res. 2017 Jun 01; 23(11):2611-2616.
View in: PubMed

Ong WL, Schouwenburg MG, van Bommel ACM, Stowell C, Allison KH, Benn KE, Browne JP, Cooter RD, Delaney GP, Duhoux FP, Ganz PA, Hancock P, Jagsi R, Knaul FM, Knip AM, Koppert LB, Kuerer HM, McLaughin S, Mureau MAM, Partridge AH, Reid DP, Sheeran L, Smith TJ, Stoutjesdijk MJ, Vrancken Peeters MJTFD, Wengström Y, Yip CH, Saunders C. A Standard Set of Value-Based Patient-Centered Outcomes for Breast Cancer: The International Consortium for Health Outcomes Measurement (ICHOM) Initiative. JAMA Oncol. 2017 May 01; 3(5):677-685.
View in: PubMed

Walsh SK, Ginsburg ES, Lehmann LS, Partridge AH. Oncofertility: Fertile Ground for Conflict Between Patient Autonomy and Medical Values. Oncologist. 2017 07; 22(7):860-863.
View in: PubMed

Vaz-Luis I, O'Neill A, Sepucha K, Miller KD, Baker E, Dang CT, Northfelt DW, Winer EP, Sledge GW, Schneider B, Partridge AH. Survival benefit needed to undergo chemotherapy: Patient and physician preferences. Cancer. 2017 Aug 01; 123(15):2821-2828.
View in: PubMed

Villarreal-Garza C, Martinez-Cannon BA, Platas A, Mohar A, Partridge AH, Gil-Moran A, Fonseca A, Vega Y, Bargallo-Rocha E, Cardona-Huerta S, Lopez-Aguirre YE, Barragan-Carrillo R, Castro-Sanchez A. Fertility concerns among breast cancer patients in Mexico. Breast. 2017 Jun; 33:71-75.
View in: PubMed

Freedman RA, Keating NL, Partridge AH, Muss HB, Hurria A, Winer EP. Surveillance Mammography in Older Patients With Breast Cancer-Can We Ever Stop?: A Review. JAMA Oncol. 2017 Mar 01; 3(3):402-409.
View in: PubMed

Cardoso F, Harbeck N, Barrios CH, Bergh J, Cortés J, El Saghir N, Francis PA, Hudis CA, Ohno S, Partridge AH, Sledge GW, Smith IE, Gelmon KA. Research needs in breast cancer. Ann Oncol. 2017 02 01; 28(2):208-217.
View in: PubMed

Denduluri N, Somerfield MR, Eisen A, Holloway JN, Hurria A, King TA, Lyman GH, Partridge AH, Telli ML, Trudeau ME, Wolff AC. Reply to L. Del Mastro and A. Prat. J Clin Oncol. 2017 Apr 01; 35(10):1139.
View in: PubMed

Rosenberg SM, Partridge AH. Looking back, moving forward: the evolution of cancer survivorship care. Lancet Oncol. 2017 01; 18(1):18-19.
View in: PubMed

Freedman RA, Foster JC, Seisler DK, Lafky JM, Muss HB, Cohen HJ, Mandelblatt J, Winer EP, Hudis CA, Partridge AH, Carey LA, Cirrincione C, Moreno-Aspitia A, Kimmick G, Jatoi A, Hurria A. Accrual of Older Patients With Breast Cancer to Alliance Systemic Therapy Trials Over Time: Protocol A151527. J Clin Oncol. 2017 Feb; 35(4):421-431.
View in: PubMed

Goddard ET, Hill RC, Nemkov T, D'Alessandro A, Hansen KC, Maller O, Mongoue-Tchokote S, Mori M, Partridge AH, Borges VF, Schedin P. The Rodent Liver Undergoes Weaning-Induced Involution and Supports Breast Cancer Metastasis. Cancer Discov. 2017 02; 7(2):177-187.
View in: PubMed

Olsen SN, Wronski A, Castaño Z, Dake B, Malone C, De Raedt T, Enos M, DeRose YS, Zhou W, Guerra S, Loda M, Welm A, Partridge AH, McAllister SS, Kuperwasser C, Cichowski K. Loss of RasGAP Tumor Suppressors Underlies the Aggressive Nature of Luminal B Breast Cancers. Cancer Discov. 2017 02; 7(2):202-217.
View in: PubMed

Irwin ML, Cartmel B, Harrigan M, Li F, Sanft T, Shockro L, O'Connor K, Campbell N, Tolaney SM, Mayer EL, Yung R, Freedman RA, Partridge AH, Ligibel JA. Effect of the LIVESTRONG at the YMCA exercise program on physical activity, fitness, quality of life, and fatigue in cancer survivors. Cancer. 2017 Apr 01; 123(7):1249-1258.
View in: PubMed

Freedman RA, Seisler DK, Foster JC, Sloan JA, Lafky JM, Kimmick GG, Hurria A, Cohen HJ, Winer EP, Hudis CA, Partridge AH, Carey LA, Jatoi A, Klepin HD, Citron M, Berry DA, Shulman LN, Buzdar AU, Suman VJ, Muss HB. Risk of acute myeloid leukemia and myelodysplastic syndrome among older women receiving anthracycline-based adjuvant chemotherapy for breast cancer on Modern Cooperative Group Trials (Alliance A151511). Breast Cancer Res Treat. 2017 01; 161(2):363-373.
View in: PubMed

Graffeo R, Livraghi L, Pagani O, Goldhirsch A, Partridge AH, Garber JE. Time to incorporate germline multigene panel testing into breast and ovarian cancer patient care. Breast Cancer Res Treat. 2016 12; 160(3):393-410.
View in: PubMed

Zhou ES, Partridge AH, Syrjala KL, Michaud AL, Recklitis CJ. Evaluation and treatment of insomnia in adult cancer survivorship programs. J Cancer Surviv. 2017 02; 11(1):74-79.
View in: PubMed

Partridge AH, Hughes ME, Warner ET, Ottesen RA, Wong YN, Edge SB, Theriault RL, Blayney DW, Niland JC, Winer EP, Weeks JC, Tamimi RM. Subtype-Dependent Relationship Between Young Age at Diagnosis and Breast Cancer Survival. J Clin Oncol. 2016 09 20; 34(27):3308-14.
View in: PubMed

Ruddy KJ, Guo H, Baker EL, Goldstein MJ, Mullaney EE, Shulman LN, Partridge AH. Randomized phase 2 trial of a coordinated breast cancer follow-up care program. Cancer. 2016 Nov 15; 122(22):3546-3554.
View in: PubMed

Warner ET, Ballman KV, Strand C, Boughey JC, Buzdar AU, Carey LA, Sikov WM, Partridge AH. Impact of race, ethnicity, and BMI on achievement of pathologic complete response following neoadjuvant chemotherapy for breast cancer: a pooled analysis of four prospective Alliance clinical trials (A151426). Breast Cancer Res Treat. 2016 08; 159(1):109-18.
View in: PubMed

Bright EE, Petrie KJ, Partridge AH, Stanton AL. Barriers to and facilitative processes of endocrine therapy adherence among women with breast cancer. Breast Cancer Res Treat. 2016 07; 158(2):243-51.
View in: PubMed

Zhou ES, Partridge AH, Blackmon JE, Morgan E, Recklitis CJ. A pilot videoconference group stress management program in cancer survivors: lessons learned. Rural Remote Health. 2016 Apr-Jun; 16(2):3863.
View in: PubMed

Rosenberg SM, Ruddy KJ, Tamimi RM, Gelber S, Schapira L, Come S, Borges VF, Larsen B, Garber JE, Partridge AH. BRCA1 and BRCA2 Mutation Testing in Young Women With Breast Cancer. JAMA Oncol. 2016 Jun 01; 2(6):730-6.
View in: PubMed

Truong SR, Barry WT, Moslehi JJ, Baker EL, Mayer EL, Partridge AH. Evaluating the Utility of Baseline Cardiac Function Screening in Early-Stage Breast Cancer Treatment. Oncologist. 2016 06; 21(6):666-70.
View in: PubMed

Denduluri N, Somerfield MR, Eisen A, Holloway JN, Hurria A, King TA, Lyman GH, Partridge AH, Telli ML, Trudeau ME, Wolff AC. Selection of Optimal Adjuvant Chemotherapy Regimens for Human Epidermal Growth Factor Receptor 2 (HER2) -Negative and Adjuvant Targeted Therapy for HER2-Positive Breast Cancers: An American Society of Clinical Oncology Guideline Adaptation of the Cancer Care Ontario Clinical Practice Guideline. J Clin Oncol. 2016 07 10; 34(20):2416-27.
View in: PubMed

Waks AG, Partridge AH. Fertility Preservation in Patients With Breast Cancer: Necessity, Methods, and Safety. J Natl Compr Canc Netw. 2016 Mar; 14(3):355-63.
View in: PubMed

Ligibel JA, Giobbie-Hurder A, Shockro L, Campbell N, Partridge AH, Tolaney SM, Lin NU, Winer EP. Randomized trial of a physical activity intervention in women with metastatic breast cancer. Cancer. 2016 Apr 15; 122(8):1169-77.
View in: PubMed

Zhou ES, Partridge AH, Recklitis CJ. A pilot trial of brief group cognitive-behavioral treatment for insomnia in an adult cancer survivorship program. Psychooncology. 2017 06; 26(6):843-848.
View in: PubMed

Paluch-Shimon S, Pagani O, Partridge AH, Bar-Meir E, Fallowfield L, Fenlon D, Friedman E, Gelmon K, Gentilini O, Geraghty J, Harbeck N, Higgins S, Loibl S, Moser E, Peccatori F, Raanani H, Kaufman B, Cardoso F. Second international consensus guidelines for breast cancer in young women (BCY2). Breast. 2016 Apr; 26:87-99.
View in: PubMed

Lambertini M, Del Mastro L, Pescio MC, Andersen CY, Azim HA, Peccatori FA, Costa M, Revelli A, Salvagno F, Gennari A, Ubaldi FM, La Sala GB, De Stefano C, Wallace WH, Partridge AH, Anserini P. Cancer and fertility preservation: international recommendations from an expert meeting. BMC Med. 2016 Jan 04; 14:1.
View in: PubMed

Ruddy KJ, Risendal BC, Garber JE, Partridge AH. Cancer Survivorship Care: An Opportunity to Revisit Cancer Genetics. J Clin Oncol. 2016 Feb 20; 34(6):539-41.
View in: PubMed

Walker HE, Rosenberg SM, Stanton AL, Petrie KJ, Partridge AH. Perceptions, Attributions, and Emotions Toward Endocrine Therapy in Young Women with Breast Cancer. J Adolesc Young Adult Oncol. 2016 Mar; 5(1):16-23.
View in: PubMed

Partridge AH. Prevention of Premature Menopause and Preservation of Fertility in Young Cancer Survivors: Hopeful Though Modest Long-term Results. JAMA. 2015 Dec 22-29; 314(24):2625-7.
View in: PubMed

Berry DL, Blonquist TM, Hong F, Halpenny B, Partridge AH. Self-reported adherence to oral cancer therapy: relationships with symptom distress, depression, and personal characteristics. Patient Prefer Adherence. 2015; 9:1587-92.
View in: PubMed

Rosenberg SM, Partridge AH. Management of breast cancer in very young women. Breast. 2015 Nov; 24 Suppl 2:S154-8.
View in: PubMed

Partridge AH. Chemotherapy in Premenopausal Breast Cancer Patients. Breast Care (Basel). 2015 Oct; 10(5):307-10.
View in: PubMed

Rosenberg SM, Newman LA, Partridge AH. Breast Cancer in Young Women: Rare Disease or Public Health Problem? JAMA Oncol. 2015 Oct; 1(7):877-8.
View in: PubMed

Ballman KV, Buzdar A, Carey LA, Sikov WM, Strand C, Partridge AH. Age, race, BMI, and pathologic complete response following neoadjuvant chemotherapy: An analysis of four alliance clinical trials. J Clin Oncol. 2015 Oct; 33(28_suppl):33.
View in: PubMed

Lambertini M, Ceppi M, Poggio F, Peccatori FA, Azim HA, Ugolini D, Pronzato P, Loibl S, Moore HC, Partridge AH, Bruzzi P, Del Mastro L. Ovarian suppression using luteinizing hormone-releasing hormone agonists during chemotherapy to preserve ovarian function and fertility of breast cancer patients: a meta-analysis of randomized studies. Ann Oncol. 2015 Dec; 26(12):2408-19.
View in: PubMed

Ruddy KJ, Greaney ML, Sprunck-Harrild K, Meyer ME, Emmons KM, Partridge AH. A qualitative exploration of supports and unmet needs of diverse young women with breast cancer. J Community Support Oncol. 2015 Sep; 13(9):323-9.
View in: PubMed

Freedman RA, Kouri EM, West DW, Rosenberg S, Partridge AH, Lii J, Keating NL. Higher Stage of Disease Is Associated With Bilateral Mastectomy Among Patients With Breast Cancer: A Population-Based Survey. Clin Breast Cancer. 2016 Apr; 16(2):105-12.
View in: PubMed

Rosenberg SM, Partridge AH. New Insights Into Nonadherence With Adjuvant Endocrine Therapy Among Young Women With Breast Cancer. J Natl Cancer Inst. 2015 Oct; 107(10).
View in: PubMed

Dietz JR, Partridge AH, Gemignani ML, Javid SH, Kuerer HM. Breast Cancer Management Updates: Young and Older, Pregnant, or Male. Ann Surg Oncol. 2015 Oct; 22(10):3219-24.
View in: PubMed

Partridge AH. More Options for Premenopausal Women With Early-Stage Hormone-Sensitive Breast Cancer. Oncology (Williston Park). 2015 Jul; 29(7):482, 492.
View in: PubMed

Partridge AH, Sepucha K, O'Neill A, Miller KD, Motley C, Swaby RF, Schneider BP, Dang CT, Northfelt DW, Sledge GW. Effect of Unblinding on Participants' Perceptions of Risk and Confidence in a Large Double-Blind Clinical Trial of Chemotherapy for Breast Cancer. JAMA Oncol. 2015 Jun; 1(3):369-74.
View in: PubMed

Collins LC, Gelber S, Marotti JD, White S, Ruddy K, Brachtel EF, Schapira L, Come SE, Borges VF, Schedin P, Warner E, Wensley T, Tamimi RM, Winer EP, Partridge AH. Molecular Phenotype of Breast Cancer According to Time Since Last Pregnancy in a Large Cohort of Young Women. Oncologist. 2015 Jul; 20(7):713-8.
View in: PubMed

Ruddy KJ, Guo H, Barry W, Dang CT, Yardley DA, Moy B, Marcom PK, Albain KS, Rugo HS, Ellis MJ, Shapira I, Wolff AC, Carey LA, Overmoyer BA, Hudis C, Krop IE, Burstein HJ, Winer EP, Partridge AH, Tolaney SM. Chemotherapy-related amenorrhea after adjuvant paclitaxel-trastuzumab (APT trial). Breast Cancer Res Treat. 2015 Jun; 151(3):589-96.
View in: PubMed

Warner ET, Tamimi RM, Hughes ME, Ottesen RA, Wong YN, Edge SB, Theriault RL, Blayney DW, Niland JC, Winer EP, Weeks JC, Partridge AH. Racial and Ethnic Differences in Breast Cancer Survival: Mediating Effect of Tumor Characteristics and Sociodemographic and Treatment Factors. J Clin Oncol. 2015 Jul 10; 33(20):2254-61.
View in: PubMed

Rosenberg SM, Sepucha K, Ruddy KJ, Tamimi RM, Gelber S, Meyer ME, Schapira L, Come SE, Borges VF, Golshan M, Winer EP, Partridge AH. Local Therapy Decision-Making and Contralateral Prophylactic Mastectomy in Young Women with Early-Stage Breast Cancer. Ann Surg Oncol. 2015 Nov; 22(12):3809-15.
View in: PubMed

Rosenberg SM, Stanton AL, Petrie KJ, Partridge AH. Symptoms and Symptom Attribution Among Women on Endocrine Therapy for Breast Cancer. Oncologist. 2015 Jun; 20(6):598-604.
View in: PubMed

Borstelmann NA, Rosenberg SM, Ruddy KJ, Tamimi RM, Gelber S, Schapira L, Come S, Borges V, Morgan E, Partridge AH. Partner support and anxiety in young women with breast cancer. Psychooncology. 2015 Dec; 24(12):1679-85.
View in: PubMed

Moore HC, Unger JM, Phillips KA, Boyle F, Hitre E, Porter D, Francis PA, Goldstein LJ, Gomez HL, Vallejos CS, Partridge AH, Dakhil SR, Garcia AA, Gralow J, Lombard JM, Forbes JF, Martino S, Barlow WE, Fabian CJ, Minasian L, Meyskens FL, Gelber RD, Hortobagyi GN, Albain KS. Goserelin for ovarian protection during breast-cancer adjuvant chemotherapy. N Engl J Med. 2015 Mar 05; 372(10):923-32.
View in: PubMed

Partridge AH, Rumble RB, Smith IE. Reply to C. Twelves et Al. J Clin Oncol. 2015 Apr 10; 33(11):1301.
View in: PubMed

Palmer SC, Stricker CT, Panzer SL, Arvey SA, Baker KS, Casillas J, Ganz PA, McCabe MS, Nekhlyudov L, Overholser L, Partridge AH, Risendal B, Rosenstein DL, Syrjala KL, Jacobs LA. Outcomes and satisfaction after delivery of a breast cancer survivorship care plan: results of a multicenter trial. J Oncol Pract. 2015 Mar; 11(2):e222-9.
View in: PubMed

Korde LA, Partridge AH, Esser M, Lewis S, Simha J, Johnson RH. Breast Cancer in Young Women: Research Priorities. A Report of the Young Survival Coalition Research Think Tank Meeting. J Adolesc Young Adult Oncol. 2015 Mar; 4(1):34-43.
View in: PubMed

Pagani O, Ruggeri M, Manunta S, Saunders C, Peccatori F, Cardoso F, Kaufman B, Paluch-Shimon S, Gewefel H, Gallerani E, Abulkhair OM, Pistilli B, Warner E, Saloustros E, Perey L, Zaman K, Rabaglio M, Gelber S, Gelber RD, Goldhirsch A, Korde L, Azim HA, Partridge AH. Pregnancy after breast cancer: Are young patients willing to participate in clinical studies? Breast. 2015 Jun; 24(3):201-7.
View in: PubMed

Lambertini M, Ginsburg ES, Partridge AH. Update on fertility preservation in young women undergoing breast cancer and ovarian cancer therapy. Curr Opin Obstet Gynecol. 2015 Feb; 27(1):98-107.
View in: PubMed

Greaney ML, Sprunck-Harrild K, Ruddy KJ, Ligibel J, Barry WT, Baker E, Meyer M, Emmons KM, Partridge AH. Study protocol for Young & Strong: a cluster randomized design to increase attention to unique issues faced by young women with newly diagnosed breast cancer. BMC Public Health. 2015 Jan 31; 15:37.
View in: PubMed

Tolaney SM, Barry WT, Dang CT, Yardley DA, Moy B, Marcom PK, Albain KS, Rugo HS, Ellis M, Shapira I, Wolff AC, Carey LA, Overmoyer BA, Partridge AH, Guo H, Hudis CA, Krop IE, Burstein HJ, Winer EP. Adjuvant paclitaxel and trastuzumab for node-negative, HER2-positive breast cancer. N Engl J Med. 2015 Jan 08; 372(2):134-41.
View in: PubMed

Partridge AH, Jacobsen PB, Andersen BL. Challenges to Standardizing the Care for Adult Cancer Survivors: Highlighting ASCO's Fatigue and Anxiety and Depression Guidelines. Am Soc Clin Oncol Educ Book. 2015; 188-94.
View in: PubMed

Partridge AH, Smith IE, Rumble RB. Chemo- and Targeted Therapy for Women With Human Epidermal Growth Factor Receptor 2-Negative (or unknown) Advanced Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline Summary. J Oncol Pract. 2015 Jan; 11(1):42-3.
View in: PubMed

Reed SC, Partridge AH, Nekhlyudov L. Shared Medical Appointments in Cancer Survivorship Care: A Review of the Literature. J Oncol Pract. 2015 01; 11(1):6-11.
View in: PubMed

Montazeri K, Unitt C, Foody JM, Harris JR, Partridge AH, Moslehi J. ABCDE steps to prevent heart disease in breast cancer survivors. Circulation. 2014 Oct 28; 130(18):e157-9.
View in: PubMed

Seah DS, Lin NU, Curley C, Weiner EP, Partridge AH. Informational needs and the quality of life of patients in their first year after metastatic breast cancer diagnosis. J Community Support Oncol. 2014 Oct; 12(10):347-54.
View in: PubMed

Partridge AH, Seah DS, King T, Leighl NB, Hauke R, Wollins DS, Von Roenn JH. Developing a service model that integrates palliative care throughout cancer care: the time is now. J Clin Oncol. 2014 Oct 10; 32(29):3330-6.
View in: PubMed

Partridge AH, Rumble RB, Carey LA, Come SE, Davidson NE, Di Leo A, Gralow J, Hortobagyi GN, Moy B, Yee D, Brundage SB, Danso MA, Wilcox M, Smith IE. Chemotherapy and targeted therapy for women with human epidermal growth factor receptor 2-negative (or unknown) advanced breast cancer: American Society of Clinical Oncology Clinical Practice Guideline. J Clin Oncol. 2014 Oct 10; 32(29):3307-29.
View in: PubMed

Azim HA, Partridge AH. Biology of breast cancer in young women. Breast Cancer Res. 2014 Aug 27; 16(4):427.
View in: PubMed

Petrie KJ, Myrtveit SM, Partridge AH, Stephens M, Stanton AL. The relationship between the belief in a genetic cause for breast cancer and bilateral mastectomy. Health Psychol. 2015 May; 34(5):473-6.
View in: PubMed

Berry DL, Hong F, Halpenny B, Partridge A, Fox E, Fann JR, Wolpin S, Lober WB, Bush N, Parvathaneni U, Amtmann D, Ford R. The electronic self report assessment and intervention for cancer: promoting patient verbal reporting of symptom and quality of life issues in a randomized controlled trial. BMC Cancer. 2014 Jul 12; 14:513.
View in: PubMed

Unger JM, Phillips KA, Boyle FM, Hitre E, Porter DJ, Francis PA, Minasian LM, Gelber RD, Goldstein LJ, Gomez HL, Vallejos C, Partridge AH, Dakhil SR, Martino S, Barlow WE, Fabian CJ, Meyskens FL, Hortobagyi GN, Albain KS. Phase III trial (Prevention of Early Menopause Study [POEMS]-SWOG S0230) of LHRH analog during chemotherapy (CT) to reduce ovarian failure in early-stage, hormone receptor-negative breast cancer: An international Intergroup trial of SWOG, IBCSG, ECOG, and CALGB (Alliance). J Clin Oncol. 2014 Jun 20; 32(18_suppl):LBA505.
View in: PubMed

Trivers KF, Fink AK, Partridge AH, Oktay K, Ginsburg ES, Li C, Pollack LA. Estimates of young breast cancer survivors at risk for infertility in the U.S. Oncologist. 2014 Aug; 19(8):814-22.
View in: PubMed

Ruddy KJ, DeSantis SD, Barry W, Guo H, Block CC, Borges V, Winer EP, Partridge AH. Extended therapy with letrozole and ovarian suppression in premenopausal patients with breast cancer after tamoxifen. Clin Breast Cancer. 2014 Dec; 14(6):413-6.
View in: PubMed

Rosenberg SM, Partridge AH. Contralateral Prophylactic Mastectomy: An Opportunity for Shared Decision Making. JAMA Surg. 2014 Jun; 149(6):589-90.
View in: PubMed

Rosenberg SM, Tamimi RM, Gelber S, Ruddy KJ, Bober SL, Kereakoglow S, Borges VF, Come SE, Schapira L, Partridge AH. Treatment-related amenorrhea and sexual functioning in young breast cancer survivors. Cancer. 2014 Aug 01; 120(15):2264-71.
View in: PubMed

Stanton AL, Petrie KJ, Partridge AH. Contributors to nonadherence and nonpersistence with endocrine therapy in breast cancer survivors recruited from an online research registry. Breast Cancer Res Treat. 2014 Jun; 145(2):525-34.
View in: PubMed

Partridge AH, Pagani O, Abulkhair O, Aebi S, Amant F, Azim HA, Costa A, Delaloge S, Freilich G, Gentilini OD, Harbeck N, Kelly CM, Loibl S, Meirow D, Peccatori F, Kaufmann B, Cardoso F. First international consensus guidelines for breast cancer in young women (BCY1). Breast. 2014 Jun; 23(3):209-20.
View in: PubMed

Gropper AB, Calvillo KZ, Dominici L, Troyan S, Rhei E, Economy KE, Tung NM, Schapira L, Meisel JL, Partridge AH, Mayer EL. Sentinel lymph node biopsy in pregnant women with breast cancer. Ann Surg Oncol. 2014 Aug; 21(8):2506-11.
View in: PubMed

Andersen BL, DeRubeis RJ, Berman BS, Gruman J, Champion VL, Massie MJ, Holland JC, Partridge AH, Bak K, Somerfield MR, Rowland JH. Screening, assessment, and care of anxiety and depressive symptoms in adults with cancer: an American Society of Clinical Oncology guideline adaptation. J Clin Oncol. 2014 May 20; 32(15):1605-19.
View in: PubMed

Ruddy KJ, O'Neill A, Miller KD, Schneider BP, Baker E, Sparano JA, Dang C, Northfelt DW, Sledge GW, Partridge AH. Biomarker prediction of chemotherapy-related amenorrhea in premenopausal women with breast cancer participating in E5103. Breast Cancer Res Treat. 2014 Apr; 144(3):591-7.
View in: PubMed

Ruddy KJ, Gelber SI, Tamimi RM, Ginsburg ES, Schapira L, Come SE, Borges VF, Meyer ME, Partridge AH. Prospective study of fertility concerns and preservation strategies in young women with breast cancer. J Clin Oncol. 2014 Apr 10; 32(11):1151-6.
View in: PubMed

Berry DL, Hong F, Halpenny B, Partridge AH, Fann JR, Wolpin S, Lober WB, Bush NE, Parvathaneni U, Back AL, Amtmann D, Ford R. Electronic self-report assessment for cancer and self-care support: results of a multicenter randomized trial. J Clin Oncol. 2014 Jan 20; 32(3):199-205.
View in: PubMed

Partridge AH, Gelber S, Gelber R. Reply to D. Serraino et al. J Clin Oncol. 2014 Jan 10; 32(2):161.
View in: PubMed

Ruddy KJ, Greaney ML, Sprunck-Harrild K, Meyer ME, Emmons KM, Partridge AH. Young Women with Breast Cancer: A Focus Group Study of Unmet Needs. J Adolesc Young Adult Oncol. 2013 Dec 01; 2(4):153-160.
View in: PubMed

McCabe MS, Partridge AH, Grunfeld E, Hudson MM. Risk-based health care, the cancer survivor, the oncologist, and the primary care physician. Semin Oncol. 2013 Dec; 40(6):804-12.
View in: PubMed

Ruddy KJ, Gelber S, Tamimi RM, Schapira L, Come SE, Meyer ME, Winer EP, Partridge AH. Breast cancer presentation and diagnostic delays in young women. Cancer. 2014 Jan 01; 120(1):20-5.
View in: PubMed

Warner ET, Colditz GA, Palmer JR, Partridge AH, Rosner BA, Tamimi RM. Reproductive factors and risk of premenopausal breast cancer by age at diagnosis: are there differences before and after age 40? Breast Cancer Res Treat. 2013 Nov; 142(1):165-75.
View in: PubMed

Ruddy KJ, Desantis SD, Gelman RS, Wu AH, Punglia RS, Mayer EL, Tolaney SM, Winer EP, Partridge AH, Burstein HJ. Personalized medicine in breast cancer: tamoxifen, endoxifen, and CYP2D6 in clinical practice. Breast Cancer Res Treat. 2013 Oct; 141(3):421-7.
View in: PubMed

Rosenberg SM, Tracy MS, Meyer ME, Sepucha K, Gelber S, Hirshfield-Bartek J, Troyan S, Morrow M, Schapira L, Come SE, Winer EP, Partridge AH. Perceptions, knowledge, and satisfaction with contralateral prophylactic mastectomy among young women with breast cancer: a cross-sectional survey. Ann Intern Med. 2013 Sep 17; 159(6):373-81.
View in: PubMed

Ganz PA, Yip CH, Gralow JR, Distelhorst SR, Albain KS, Andersen BL, Bevilacqua JL, de Azambuja E, El Saghir NS, Kaur R, McTiernan A, Partridge AH, Rowland JH, Singh-Carlson S, Vargo MM, Thompson B, Anderson BO. Supportive care after curative treatment for breast cancer (survivorship care): resource allocations in low- and middle-income countries. A Breast Health Global Initiative 2013 consensus statement. Breast. 2013 Oct; 22(5):606-15.
View in: PubMed

Cardoso F, Bese N, Distelhorst SR, Bevilacqua JL, Ginsburg O, Grunberg SM, Gralla RJ, Steyn A, Pagani O, Partridge AH, Knaul FM, Aapro MS, Andersen BL, Thompson B, Gralow JR, Anderson BO. Supportive care during treatment for breast cancer: resource allocations in low- and middle-income countries. A Breast Health Global Initiative 2013 consensus statement. Breast. 2013 Oct; 22(5):593-605.
View in: PubMed

Freedman RA, Partridge AH. Management of breast cancer in very young women. Breast. 2013 Aug; 22 Suppl 2:S176-9.
View in: PubMed

Tracy MS, Rosenberg SM, Dominici L, Partridge AH. Contralateral prophylactic mastectomy in women with breast cancer: trends, predictors, and areas for future research. Breast Cancer Res Treat. 2013 Aug; 140(3):447-52.
View in: PubMed

Meisel JL, Economy KE, Calvillo KZ, Schapira L, Tung NM, Gelber S, Kereakoglow S, Partridge AH, Mayer EL. Contemporary multidisciplinary treatment of pregnancy-associated breast cancer. Springerplus. 2013 Dec; 2(1):297.
View in: PubMed

Partridge AH, Gelber S, Piccart-Gebhart MJ, Focant F, Scullion M, Holmes E, Winer EP, Gelber RD. Effect of age on breast cancer outcomes in women with human epidermal growth factor receptor 2-positive breast cancer: results from a herceptin adjuvant trial. J Clin Oncol. 2013 Jul 20; 31(21):2692-8.
View in: PubMed

Rosenberg SM, Partridge AH. Premature menopause in young breast cancer: effects on quality of life and treatment interventions. J Thorac Dis. 2013 Jun; 5 Suppl 1:S55-61.
View in: PubMed

Loren AW, Mangu PB, Beck LN, Brennan L, Magdalinski AJ, Partridge AH, Quinn G, Wallace WH, Oktay K. Fertility preservation for patients with cancer: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol. 2013 Jul 01; 31(19):2500-10.
View in: PubMed

Turner NH, Partridge A, Sanna G, Di Leo A, Biganzoli L. Utility of gonadotropin-releasing hormone agonists for fertility preservation in young breast cancer patients: the benefit remains uncertain. Ann Oncol. 2013 Sep; 24(9):2224-35.
View in: PubMed

Henry NL, Xia R, Banerjee M, Gersch C, McConnell D, Giacherio D, Schott AF, Pearlman M, Stearns V, Partridge AH, Hayes DF. Predictors of recovery of ovarian function during aromatase inhibitor therapy. Ann Oncol. 2013 Aug; 24(8):2011-6.
View in: PubMed

Ruddy KJ, Meyer ME, Giobbie-Hurder A, Emmons KM, Weeks JC, Winer EP, Partridge AH. Long-term risk perceptions of women with ductal carcinoma in situ. Oncologist. 2013; 18(4):362-8.
View in: PubMed

Bunnell CA, Gross AH, Weingart SN, Kalfin MJ, Partridge A, Lane S, Burstein HJ, Fine B, Hilton NA, Sullivan C, Hagemeister EE, Kelly AE, Colicchio L, Szabatura AH, Winer EP, Salisbury M, Mann S. High performance teamwork training and systems redesign in outpatient oncology. BMJ Qual Saf. 2013 May; 22(5):405-13.
View in: PubMed

Ruddy KJ, Giobbie-Hurder A, Giordano SH, Goldfarb S, Kereakoglow S, Winer EP, Partridge AH. Quality of life and symptoms in male breast cancer survivors. Breast. 2013 Apr; 22(2):197-199.
View in: PubMed

Partridge AH. Cancer survivorship and the young breast cancer patient: addressing the important issues. Oncologist. 2013; 18(8):e19-20.
View in: PubMed

Roth BJ, Krilov L, Adams S, Aghajanian CA, Bach P, Braiteh F, Brose MS, Ellis LM, Erba H, George DJ, Gilbert MR, Jacobson JO, Larsen EC, Lichtman SM, Partridge AH, Patel JD, Quinn DI, Robison LL, von Roenn JH, Samlowski W, Schwartz GK, Vogelzang NJ. Clinical cancer advances 2012: annual report on progress against cancer from the american society of clinical oncology. J Clin Oncol. 2013 Jan 01; 31(1):131-61.
View in: PubMed

Gross A, Kalfin M, Partridge AH, Lane S, Burstein HJ, Fine B, Hilton N, Sullivan C, Colicchio L, Hagemeister E, Kelly A, Szabatura A, Winer EP, Mann S, Weingart S. Implementation of team training in outpatient breast oncology. J Clin Oncol. 2012 Dec; 30(34_suppl):83.
View in: PubMed

Blinder VS, Norris VW, Peacock NW, Griggs JJ, Harrington DP, Moore A, Theriault RL, Partridge AH. Patient perspectives on breast cancer treatment plan and summary documents in community oncology care: a pilot program. Cancer. 2013 Jan 01; 119(1):164-72.
View in: PubMed

Partridge AH, Norris VW, Blinder VS, Cutter BA, Halpern MT, Malin J, Neuss MN, Wolff AC. Implementing a breast cancer registry and treatment plan/summary program in clinical practice: a pilot program. Cancer. 2013 Jan 01; 119(1):158-63.
View in: PubMed

Toi M, Benson JR, Winer EP, Forbes JF, von Minckwitz G, Golshan M, Robertson JF, Sasano H, Cole BF, Chow LW, Pegram MD, Han W, Huang CS, Ikeda T, Kanao S, Lee ES, Noguchi S, Ohno S, Partridge AH, Rouzier R, Tozaki M, Sugie T, Yamauchi A, Inamoto T. Preoperative systemic therapy in locoregional management of early breast cancer: highlights from the Kyoto Breast Cancer Consensus Conference. Breast Cancer Res Treat. 2012 Dec; 136(3):919-26.
View in: PubMed

Rosenberg SM, Tamimi RM, Gelber S, Ruddy KJ, Kereakoglow S, Borges VF, Come SE, Schapira L, Winer EP, Partridge AH. Body image in recently diagnosed young women with early breast cancer. Psychooncology. 2013 Aug; 22(8):1849-55.
View in: PubMed

Warner ET, Tamimi RM, Hughes ME, Ottesen RA, Wong YN, Edge SB, Theriault RL, Blayney DW, Niland JC, Winer EP, Weeks JC, Partridge AH. Time to diagnosis and breast cancer stage by race/ethnicity. Breast Cancer Res Treat. 2012 Dec; 136(3):813-21.
View in: PubMed

Ruddy KJ, Partridge AH. Fertility (male and female) and menopause. J Clin Oncol. 2012 Oct 20; 30(30):3705-11.
View in: PubMed

Freedman RA, Virgo KS, Labadie J, He Y, Partridge AH, Keating NL. Receipt of locoregional therapy among young women with breast cancer. Breast Cancer Res Treat. 2012 Oct; 135(3):893-906.
View in: PubMed

Bober SL, Giobbie-Hurder A, Emmons KM, Winer E, Partridge A. Psychosexual functioning and body image following a diagnosis of ductal carcinoma in situ. J Sex Med. 2013 Feb; 10(2):370-7.
View in: PubMed

Ruddy KJ, Pitcher BN, Archer LE, Cohen HJ, Winer EP, Hudis CA, Muss HB, Partridge AH. Persistence, adherence, and toxicity with oral CMF in older women with early-stage breast cancer (Adherence Companion Study 60104 for CALGB 49907). Ann Oncol. 2012 Dec; 23(12):3075-81.
View in: PubMed

Sepucha KR, Belkora JK, Chang Y, Cosenza C, Levin CA, Moy B, Partridge A, Lee CN. Measuring decision quality: psychometric evaluation of a new instrument for breast cancer surgery. BMC Med Inform Decis Mak. 2012 Jun 08; 12:51.
View in: PubMed

Partridge AH, Ruddy KJ, Kennedy J, Winer EP. Model program to improve care for a unique cancer population: young women with breast cancer. J Oncol Pract. 2012 Sep; 8(5):e105-10.
View in: PubMed

Partridge AH, Hughes ME, Ottesen RA, Wong YN, Edge SB, Theriault RL, Blayney DW, Niland JC, Winer EP, Weeks JC, Tamimi RM. The effect of age on delay in diagnosis and stage of breast cancer. Oncologist. 2012; 17(6):775-82.
View in: PubMed

Partridge AH, Elmore JG, Saslow D, McCaskill-Stevens W, Schnitt SJ. Challenges in ductal carcinoma in situ risk communication and decision-making: report from an American Cancer Society and National Cancer Institute workshop. CA Cancer J Clin. 2012 May-Jun; 62(3):203-10.
View in: PubMed

Meisel JL, Domchek SM, Vonderheide RH, Giobbie-Hurder A, Lin NU, Winer EP, Partridge AH. Quality of life in long-term survivors of metastatic breast cancer. Clin Breast Cancer. 2012 Apr; 12(2):119-26.
View in: PubMed

Katz ML, Archer LE, Peppercorn JM, Kereakoglow S, Collyar DE, Burstein HJ, Schilsky RL, Partridge AH. Patient advocates' role in clinical trials: perspectives from Cancer and Leukemia Group B investigators and advocates. Cancer. 2012 Oct 01; 118(19):4801-5.
View in: PubMed

Trevino KM, Maciejewski PK, Fasciano K, Greer J, Partridge A, Kacel EL, Block S, Prigerson HG. Coping and psychological distress in young adults with advanced cancer. J Support Oncol. 2012 May-Jun; 10(3):124-30.
View in: PubMed

Partridge AH. Ovarian suppression for prevention of premature menopause and infertility: empty promise or effective therapy? J Clin Oncol. 2012 Feb 10; 30(5):479-81.
View in: PubMed

Gavin MC, Morse D, Partridge AH, Levy BD, Loscalzo J. Clinical problem-solving. Breathless. N Engl J Med. 2012 Jan 05; 366(1):75-81.
View in: PubMed

Abusief ME, Missmer SA, Ginsburg ES, Weeks JC, Partridge AH. Relationship between reproductive history, anthropometrics, lifestyle factors, and the likelihood of persistent chemotherapy-related amenorrhea in women with premenopausal breast cancer. Fertil Steril. 2012 Jan; 97(1):154-9.
View in: PubMed

Ruddy KJ, Partridge AH. The unique reproductive concerns of young women with breast cancer. Adv Exp Med Biol. 2012; 732:77-87.
View in: PubMed

Ross JJ, Vaidya A, Gavin MC, Morse D, Partridge AH. Interactive medical case. Breathless. N Engl J Med. 2011 Dec 22; 365(25):e47.
View in: PubMed

Mayer EL, Gropper AB, Neville BA, Partridge AH, Cameron DB, Winer EP, Earle CC. Breast cancer survivors' perceptions of survivorship care options. J Clin Oncol. 2012 Jan 10; 30(2):158-63.
View in: PubMed

Collins LC, Marotti JD, Gelber S, Cole K, Ruddy K, Kereakoglow S, Brachtel EF, Schapira L, Come SE, Winer EP, Partridge AH. Pathologic features and molecular phenotype by patient age in a large cohort of young women with breast cancer. Breast Cancer Res Treat. 2012 Feb; 131(3):1061-6.
View in: PubMed

Lee CN, Chang Y, Adimorah N, Belkora JK, Moy B, Partridge AH, Ollila DW, Sepucha KR. Decision making about surgery for early-stage breast cancer. J Am Coll Surg. 2012 Jan; 214(1):1-10.
View in: PubMed

Basch E, Somerfield MR, Partridge A, Schnipper L, Lyman GH. Commentary: should cost and comparative value of treatments be considered in clinical practice guidelines? J Oncol Pract. 2011 Nov; 7(6):398-401.
View in: PubMed

Freedman RA, Partridge AH. Adjuvant therapies for very young women with early stage breast cancer. Breast. 2011 Oct; 20 Suppl 3:S146-9.
View in: PubMed

Ginsburg ES, Partridge AH. Reproductive endocrinology: triptorelin ovarian suppression during breast cancer chemotherapy. Nat Rev Endocrinol. 2011 Sep 20; 7(11):637-8.
View in: PubMed

Griggs JJ, Somerfield MR, Anderson H, Henry NL, Hudis CA, Khatcheressian JL, Partridge AH, Prestrud AA, Davidson NE. American Society of Clinical Oncology endorsement of the cancer care Ontario practice guideline on adjuvant ovarian ablation in the treatment of premenopausal women with early-stage invasive breast cancer. J Clin Oncol. 2011 Oct 10; 29(29):3939-42.
View in: PubMed

Pagani O, Partridge A, Korde L, Badve S, Bartlett J, Albain K, Gelber R, Goldhirsch A. Pregnancy after breast cancer: if you wish, ma'am. Breast Cancer Res Treat. 2011 Sep; 129(2):309-17.
View in: PubMed

Freedman RA, Bullitt E, Sun L, Gelman R, Harris G, Ligibel JA, Krop IE, Partridge AH, Eisenberg E, Winer EP, Lin NU. A phase II study of sagopilone (ZK 219477; ZK-EPO) in patients with breast cancer and brain metastases. Clin Breast Cancer. 2011 Dec; 11(6):376-83.
View in: PubMed

Schneider BP, Li L, Miller K, Flockhart D, Radovich M, Hancock BA, Kassem N, Foroud T, Koller DL, Badve SS, Li Z, Partridge AH, O'Neill AM, Sparano JA, Dang CT, Northfelt DW, Smith ML, Railey E, Sledge GW. Genetic associations with taxane-induced neuropathy by a genome-wide association study (GWAS) in E5103. J Clin Oncol. 2011 May 20; 29(15_suppl):1000.
View in: PubMed

Trevino KM, Fasciano K, Partridge AH, Maciejewski P, Kacel E, Jimenez R, Block S, Prigerson HG. Understanding the psychosocial needs of young adults with cancer: Identifying targets for clinical intervention. J Clin Oncol. 2011 May 20; 29(15_suppl):9068.
View in: PubMed

Blinder VS, Norris VW, Peacock NW, Griggs JJ, Harrington DP, Moore A, Theriault RL, Partridge AH. Patient perspectives on a treatment plan and summary program in community oncology care. J Clin Oncol. 2011 May 20; 29(15_suppl):6027.
View in: PubMed

Ruddy KJ, Gelber S, Tamimi RM, Ginsburg ES, Schapira L, Come SE, Meyer ME, Winer EP, Partridge AH. Fertility concerns in young women with breast cancer: Results from a prospective cohort study. J Clin Oncol. 2011 May 20; 29(15_suppl):6025.
View in: PubMed

Partridge AH, Norris VW, Blinder VS, Cutter BA, Halpern MT, Malin J, Neuss MN, Wolff AC. The ASCO Breast Cancer Registry pilot: Implementation of a multisite community practice registry and treatment plan/summary program. J Clin Oncol. 2011 May 20; 29(15_suppl):6101.
View in: PubMed

Cigler T, Higgins MJ, Szymonifka J, Partridge AH, Ligibel JA, Finkelstein D, Come SE, Ryan PD, Goss PE. A phase II clinical trial of drug withdrawal in women with progressive breast cancer while on aromatase inhibitor therapy. J Clin Oncol. 2011 May 20; 29(15_suppl):559.
View in: PubMed

Kornblith AB, Lan L, Archer L, Partridge A, Kimmick G, Hudis C, Winer E, Casey R, Bennett S, Cohen HJ, Muss HB. Quality of life of older patients with early-stage breast cancer receiving adjuvant chemotherapy: a companion study to cancer and leukemia group B 49907. J Clin Oncol. 2011 Mar 10; 29(8):1022-8.
View in: PubMed

Ruddy KJ, Gelber S, Ginsburg ES, Schapira L, Abusief ME, Meyer ME, Partridge AH. Menopausal symptoms and fertility concerns in premenopausal breast cancer survivors: a comparison to age- and gravidity-matched controls. Menopause. 2011 Jan; 18(1):105-8.
View in: PubMed

Lee CN, Belkora J, Chang Y, Moy B, Partridge A, Sepucha K. Are patients making high-quality decisions about breast reconstruction after mastectomy? [outcomes article]. Plast Reconstr Surg. 2011 Jan; 127(1):18-26.
View in: PubMed

Joffe H, Partridge A, Giobbie-Hurder A, Li X, Habin K, Goss P, Winer E, Garber J. Augmentation of venlafaxine and selective serotonin reuptake inhibitors with zolpidem improves sleep and quality of life in breast cancer patients with hot flashes: a randomized, double-blind, placebo-controlled trial. Menopause. 2010 Sep-Oct; 17(5):908-16.
View in: PubMed

Ligibel JA, Partridge A, Giobbie-Hurder A, Campbell N, Shockro L, Salinardi T, Salinardri T, Winer EP. Physical and psychological outcomes among women in a telephone-based exercise intervention during adjuvant therapy for early stage breast cancer. J Womens Health (Larchmt). 2010 Aug; 19(8):1553-9.
View in: PubMed

Partridge A. Non-adherence: a new epidemic? Eur J Cancer. 2010 Jul; 46(10):1767.
View in: PubMed

Weingart SN, Toro J, Spencer J, Duncombe D, Gross A, Bartel S, Miransky J, Partridge A, Shulman LN, Connor M. Medication errors involving oral chemotherapy. Cancer. 2010 May 15; 116(10):2455-64.
View in: PubMed

Peppercorn J, Shapira I, Collyar D, Deshields T, Lin N, Krop I, Grunwald H, Friedman P, Partridge AH, Schilsky RL, Bertagnolli MM. Ethics of mandatory research biopsy for correlative end points within clinical trials in oncology. J Clin Oncol. 2010 May 20; 28(15):2635-40.
View in: PubMed

Partridge AH, Archer L, Kornblith AB, Gralow J, Grenier D, Perez E, Wolff AC, Wang X, Kastrissios H, Berry D, Hudis C, Winer E, Muss H. Adherence and persistence with oral adjuvant chemotherapy in older women with early-stage breast cancer in CALGB 49907: adherence companion study 60104. J Clin Oncol. 2010 May 10; 28(14):2418-22.
View in: PubMed

de Moor JS, Partridge AH, Winer EP, Ligibel J, Emmons KM. The role of socioeconomic status in adjustment after ductal carcinoma in situ. Cancer. 2010 Mar 01; 116(5):1218-25.
View in: PubMed

Abusief ME, Missmer SA, Ginsburg ES, Weeks JC, Partridge AH. The effects of paclitaxel, dose density, and trastuzumab on treatment-related amenorrhea in premenopausal women with breast cancer. Cancer. 2010 Feb 15; 116(4):791-8.
View in: PubMed

Partridge AH, Winer EP. On mammography--more agreement than disagreement. N Engl J Med. 2009 Dec 24; 361(26):2499-501.
View in: PubMed

Ruddy KJ, Gelber S, Shin J, Garber JE, Rosenberg R, Przypysny M, Partridge AH. Genetic testing in young women with breast cancer: results from a Web-based survey. Ann Oncol. 2010 Apr; 21(4):741-7.
View in: PubMed

Ozanne EM, Partridge A, Moy B, Ellis KJ, Sepucha KR. Doctor-patient communication about advance directives in metastatic breast cancer. J Palliat Med. 2009 Jun; 12(6):547-53.
View in: PubMed

Ruddy KJ, Gelber S, Tamimi R, Schapira L, Come S, Kereakoglow S, Lin NU, Winer EP, Partridge AH. Presentation of breast cancer in young women. J Clin Oncol. 2009 May 20; 27(15_suppl):6608.
View in: PubMed

Gold JM, Najita JS, Lester S, Richardson AL, Morganstern DE, Chen WY, Partridge AH, Krop IE, Winer EP, Burstein HJ. Personalizing treatment in early-stage breast cancer: The role of standard clinical factors and genomic information in adjuvant chemotherapy decision making. J Clin Oncol. 2009 May 20; 27(15_suppl):572.
View in: PubMed

Muss HB, Berry DA, Cirrincione CT, Theodoulou M, Mauer AM, Kornblith AB, Partridge AH, Dressler LG, Cohen HJ, Becker HP, Kartcheske PA, Wheeler JD, Perez EA, Wolff AC, Gralow JR, Burstein HJ, Mahmood AA, Magrinat G, Magrinat G, Parker BA, Hart RD, Grenier D, Norton L, Hudis CA, Winer EP. Adjuvant chemotherapy in older women with early-stage breast cancer. N Engl J Med. 2009 May 14; 360(20):2055-65.
View in: PubMed

Partridge AH, Ruddy KJ, Gelber S, Schapira L, Abusief M, Meyer M, Ginsburg E. Ovarian reserve in women who remain premenopausal after chemotherapy for early stage breast cancer. Fertil Steril. 2010 Jul; 94(2):638-44.
View in: PubMed

Ruddy KJ, Partridge AH. Breast cancer in young women: clinical decision-making in the face of uncertainty. Oncology (Williston Park). 2009 May; 23(6):474, 477.
View in: PubMed

Sepucha KR, Ozanne EM, Partridge AH, Moy B. Is there a role for decision aids in advanced breast cancer? Med Decis Making. 2009 Jul-Aug; 29(4):475-82.
View in: PubMed

Mayer EL, Partridge AH, Harris LN, Gelman RS, Schumer ST, Burstein HJ, Winer EP. Tolerability of and adherence to combination oral therapy with gefitinib and capecitabine in metastatic breast cancer. Breast Cancer Res Treat. 2009 Oct; 117(3):615-23.
View in: PubMed

Ruddy KJ, Partridge AH. Adherence with adjuvant hormonal therapy for breast cancer. Ann Oncol. 2009 Mar; 20(3):401-2.
View in: PubMed

Partridge AH, Winer EP. Sharing study results with trial participants: time for action. J Clin Oncol. 2009 Feb 20; 27(6):838-9.
View in: PubMed

Ruddy KJ, Partridge AH. Fertility. Cancer Treat Res. 2009; 151:367-85.
View in: PubMed

Ruddy K, Mayer E, Partridge A. Patient adherence and persistence with oral anticancer treatment. CA Cancer J Clin. 2009 Jan-Feb; 59(1):56-66.
View in: PubMed

Ruddy KJ, Partridge AJ. Optimizing endocrine therapy in premenopausal ER-positive breast cancer patients. Oncology (Williston Park). 2009 Jan; 23(1):34, 40.
View in: PubMed

Ligibel JA, Partridge A, Giobbie-Hurder A, Golshan M, Emmons K, Winer EP. Physical activity behaviors in women with newly diagnosed ductal carcinoma-in-situ. Ann Surg Oncol. 2009 Jan; 16(1):106-12.
View in: PubMed

Peppercorn J, Partridge AH. Breast cancer in young women: a new color or a different shade of pink? J Clin Oncol. 2008 Jul 10; 26(20):3303-5.
View in: PubMed

Partridge AH, Wolff AC, Marcom PK, Kaufman PA, Zhang L, Gelman R, Moore C, Lake D, Fleming GF, Rugo HS, Atkins J, Sampson E, Collyar D, Winer EP. The impact of sharing results of a randomized breast cancer clinical trial with study participants. Breast Cancer Res Treat. 2009 May; 115(1):123-9.
View in: PubMed

Hickey M, Saunders C, Partridge A, Santoro N, Joffe H, Stearns V. Practical clinical guidelines for assessing and managing menopausal symptoms after breast cancer. Ann Oncol. 2008 Oct; 19(10):1669-80.
View in: PubMed

Partridge AH. Fertility preservation: a vital survivorship issue for young women with breast cancer. J Clin Oncol. 2008 Jun 01; 26(16):2612-3.
View in: PubMed

Partridge A, Winer JP, Golshan M, Bellon JR, Blood E, Dees EC, Sampson E, Emmons KM, Winer E. Perceptions and management approaches of physicians who care for women with ductal carcinoma in situ. Clin Breast Cancer. 2008 Jun; 8(3):275-80.
View in: PubMed

Partridge AH, Archer LE, Kornblith AB, Gralow JR, Grenier D, Perez EA, Wolff AC, Hudis CA, Winer EP, Muss H. CALGB 60104: Adherence with adjuvant capecitabine among women age 65 and older with early stage breast cancer treated on CALGB 49907. J Clin Oncol. 2008 May 20; 26(15_suppl):6542.
View in: PubMed

Ruddy KJ, Partridge AH, Gelber S, Schapira L, Abusief M, Meyer M, Winer EP, Ginsburg ES. Ovarian reserve in women who remain premenopausal after chemotherapy for early stage breast cancer. J Clin Oncol. 2008 May 20; 26(15_suppl):9571.
View in: PubMed

Muss HB, Berry DL, Cirrincione C, Theodoulou M, Mauer A, Cohen H, Partridge AH, Norton L, Hudis CA, Winer EP. Standard chemotherapy (CMF or AC) versus capecitabine in early-stage breast cancer (BC) patients aged 65 and older: Results of CALGB/CTSU 49907. J Clin Oncol. 2008 May 20; 26(15_suppl):507.
View in: PubMed

Ligibel JA, Campbell N, Partridge A, Chen WY, Salinardi T, Chen H, Adloff K, Keshaviah A, Winer EP. Impact of a mixed strength and endurance exercise intervention on insulin levels in breast cancer survivors. J Clin Oncol. 2008 Feb 20; 26(6):907-12.
View in: PubMed

Partridge A, Adloff K, Blood E, Dees EC, Kaelin C, Golshan M, Ligibel J, de Moor JS, Weeks J, Emmons K, Winer E. Risk perceptions and psychosocial outcomes of women with ductal carcinoma in situ: longitudinal results from a cohort study. J Natl Cancer Inst. 2008 Feb 20; 100(4):243-51.
View in: PubMed

Partridge AH, Gelber S, Peppercorn J, Ginsburg E, Sampson E, Rosenberg R, Przypyszny M, Winer EP. Fertility and menopausal outcomes in young breast cancer survivors. Clin Breast Cancer. 2008 Feb; 8(1):65-9.
View in: PubMed

Partridge AH, LaFountain A, Mayer E, Taylor BS, Winer E, Asnis-Alibozek A. Adherence to initial adjuvant anastrozole therapy among women with early-stage breast cancer. J Clin Oncol. 2008 Feb 01; 26(4):556-62.
View in: PubMed

Earle CC, Partridge AH. Care of the Cancer Survivor. Lyman, Supportive Care in Oncology, In Press. 2008.
View in: PubMed

Partridge AH, Winer JP, Golshan M, Bellon JR, Blood E, Dees EC, Sampson E, Emmons K, Winer E. Perceptions and Management Approaches of Physicians Who Care for Women with Ductal Carcinoma-in-situ (DCIS). J Natl Cancer Inst. 2008; 100(4):243-51.
View in: PubMed

Partridge AH. Fertility Preservation- A Vital Survivorship Issue for Young Women with Breast Cancer. J Clin Oncol, In Press. 2008.
View in: PubMed

Partridge AH, Goldhirsch A, Gelber S, Gelber R. Breast Cancer in Young Women. Diseases of the Breast, In Press. 2008.
View in: PubMed

Partridge AH, Adloff KO, Blood E, Dees EC, Kaelin C, Golshan M, Ligibel J, deMoors JS, Weeks J, Emmons K, Winer E. Risk Perceptions and Psychosocial Outcomes of Women with Ductal Carcinoma-in-situ (DCIS): Longitudinal Results from a Cohort Study. J Clin Oncol. 2008; 26(6):907-12.
View in: PubMed

Partridge AH, Ginsburg ES. Reproductive Issues in Breast Cancer Survivors. Diseases of the Breast, In Press. 2008.
View in: PubMed

Ruddy KJ, Partridge AH. Fertility. Castiglione M, ed. Adjuvant Therapy for Breast Cancer. 2008.
View in: PubMed

Partridge AH, Ruddy KJ. Fertility and Adjuvant Treatment in Young Women with Breast Cancer. In Press. 2008.
View in: PubMed

Partridge AH. Fertility Preservation Considerations in Young Women with Breast Cancer. American Society Of Clinical Oncology Annual Meeting 2008 Educational Book. 2008.
View in: PubMed

Partridge AH, Ruddy KJ. Fertility and adjuvant treatment in young women with breast cancer. Breast. 2007 Dec; 16 Suppl 2:S175-81.
View in: PubMed

Ligibel J, Partridge AH, Giobbie-Hurder A, Emmons K, Winer E. Exercise behaviors in a group of women with newly diagnosed ductal carcinoma in situ (DCIS). Proceedings from ASCO the 2007 Breast Cancer Symposium. 2007; (abstr 123).
View in: PubMed

Duffy C, Perez K, Partridge A. Implications of phytoestrogen intake for breast cancer. CA Cancer J Clin. 2007 Sep-Oct; 57(5):260-77.
View in: PubMed

Ozanne E, Sepucha K, Partridge AH, Moy B. Challenges in the end-of-life care: Commnication about advance directives between patients and providers. Proceedings from ASCO the 2007 Breast Cancer Symposium. 2007; (abstr 269).
View in: PubMed

Shin JA, Gelber S, Garber J, Rosenberg J, Przypyzny M, Winer E, Partridge AH. Genetic testing in young women with breast cancer: Results from a web-based survey. Proc Am Soc Clin Onc. 2007; (abstr 21093).
View in: PubMed

Ligibel JA, Campbell N, Chen H, Salinadi T, Chen W, Partridge AH, Mantzoros C, Winer E. Impact of physical activity on insulin levels in breast cancer survivors. Proc Am Soc Clin Oncol. 2007; (abstr 555).
View in: PubMed

Partridge A, Gelber S, Gelber RD, Castiglione-Gertsch M, Goldhirsch A, Winer E. Age of menopause among women who remain premenopausal following treatment for early breast cancer: long-term results from International Breast Cancer Study Group Trials V and VI. Eur J Cancer. 2007 Jul; 43(11):1646-53.
View in: PubMed

Peppercorn J, Blood E, Winer E, Partridge A. Association between pharmaceutical involvement and outcomes in breast cancer clinical trials. Cancer. 2007 Apr 01; 109(7):1239-46.
View in: PubMed

Weingart SN, Flug J, Brouillard D, Morway L, Partridge A, Bartel S, Shulman LN, Connor M. Oral chemotherapy safety practices at US cancer centres: questionnaire survey. BMJ. 2007 Feb 24; 334(7590):407.
View in: PubMed

Weingart SN, Brouillard D, Morway L, Partridge AH, Bartel S, Shulman LN, Connor M. Oral Chemotherapy safety practices at US cancer centres: questionaire survey. BJM. 2007.
View in: PubMed

Partridge AH, Ades T, Spicer P, Englander L, Wickerman DL. Adherence with adjuvant hormonal therapy in breast cancer: a report from the Compliance Strategic Intiative Conference. Community Oncology. 2007; 4:1-7.
View in: PubMed

Ligibel JA, Chen W, Keshaviah A, Adloff K, Partridge AH, Salinardi T, Winer EP. The impact of an exercise invention on body composition, fat distriution, and weight in breast cancer survivors. J Clin Onc. 2007.
View in: PubMed

Tolaney SM, Partridge AH, Scheib RG, Ligibel JA, Shulman LN, Winer EP, Burstein HJ. Lymphopenia in dose-dense chemotherapy for early stage breast cancer. Breast Cancer Research and Treatment. 2006; (abstr 2093).
View in: PubMed

Ligibel JA, Chen W, Keshaviah A, Adloff K, Partridge AH, Salinardi T, Winer EP. The impact of an exercise intervention on body composition, fat distribution, and weight in breast cancer survivors. Proc Am Soc Clin Onc. 2006; (abstr 590).
View in: PubMed

Ausief ME, Missmer SA, Ginsburg ES, Weeks JS, Winer EP, Partridge AH. Chemotherapy-related amenorrhea in women with early breast cancer: The effect of paclitaxel or dose density. Proc Am Soc Clin Oncol. 2006; (abstr 10560).
View in: PubMed

Abusief ME, Missmer SA, Ginsburg ES, Weeks JC, Winer EP, Partridge AH. The effect of paclitaxel, dose density and trastuzumab on chemotherapy-related amenorrhea (CRA) in premenopausal women with breast cancer. Breast Cancer Research and Treatment. 2006; (abstr 2079).
View in: PubMed

Partridge AH, LaFountain A, Taylor B, Asnis-Alibozek A. Adherence with adjuvant anastrozole therapy among women with early stage breast cancer. Breast Cancer Research and Treatment. 2006; (abstr 4044).
View in: PubMed

Tolaney SM, Partridge AH, Sheib RG, Burstein HJ, Winer EP. Pneumocystis carinii pneumonia during dose-dense chemotherapy for breast cancer. J Clin Oncol. 2006 Nov 20; 24(33):5330-1.
View in: PubMed

Sepucha K, Ozanne E, Silvia K, Partridge A, Mulley AG. An approach to measuring the quality of breast cancer decisions. Patient Educ Couns. 2007 Feb; 65(2):261-9.
View in: PubMed

Leining MG, Gelber S, Rosenberg R, Przypyszny M, Winer EP, Partridge AH. Menopausal-type symptoms in young breast cancer survivors. Ann Oncol. 2006 Dec; 17(12):1777-82.
View in: PubMed

Partridge AH, Wolff AC, Marcom PK, Kaufman PA, Moore C, Lake D, Fleming G, Rugo HS, Collyar D, Winer EP. Study participants' perceptions of the process and impact of receiving results of N9831. J Clin Oncol. 2006 Jun 20; 24(18_suppl):518.
View in: PubMed

Mayer EL, Harris LN, Partridge AH, Gelman RS, Schumer ST, Comanaru RS, Long M, Sampson E, Burstein HJ, Winer EP. Combination therapy with gefitinib and capecitabine in metastatic breast cancer (MBC): A phase I trial. J Clin Oncol. 2006 Jun 20; 24(18_suppl):10564.
View in: PubMed

Abusief ME, Missmer SA, Ginsburg ES, Weeks JC, Winer EP, Partridge AH. Chemotherapy-related amenorrhea in women with early breast cancer: The effect of paclitaxel or dose density. J Clin Oncol. 2006 Jun 20; 24(18_suppl):10506.
View in: PubMed

Mayer EL, Harris LN, Partridge AH, Gelman RS, Schumer ST, Comanaru RS, Long M, Sampson E, Burstein HJ, Winer EP. Combination therapy with gefitnib and capecitabine in metastatic breast cancer (MBC): A phase I trial. Proc Am Soc Clin Oncol. 2006; (abstr 10564).
View in: PubMed

Partridge AH, Wolff AC, Marcom PK, Kaufman PA, Moore C, Lake D, Fleming G, Rugo HS, Collyar D, Winer EP. Study Participants' perceptions of the process and impact of receiving results N9831. Proc Am Soc Clin Onc. 2006; (abstr 518).
View in: PubMed

Lee SJ, Schover LR, Partridge AH, Patrizio P, Wallace WH, Hagerty K, Beck LN, Brennan LV, Oktay K. American Society of Clinical Oncology recommendations on fertility preservation in cancer patients. J Clin Oncol. 2006 Jun 20; 24(18):2917-31.
View in: PubMed

Partridge AH. Non-adherence to endocrine therapy for breast cancer. Ann Oncol. 2006 Feb; 17(2):183-4.
View in: PubMed

Burstein HJ, Mayer E, Partridge AH, O'Kane H, Litsas G, Come SE, Hudis CA, Goldstein DF, Muss HB, Winer EP, Garber JE. Inadvertent Use of Aromatase Inhibitors in Patients with Breast Cancer with Residual Ovarian Function: Cases and Lessons. Clin Breast Ca. 2006; 7:158-61.
View in: PubMed

Partridge AH. Non-adherence to endocrine therapy for breast cancer. Annals of Oncology. 2006; 17:183-84.
View in: PubMed

Lee SJ, Schover LR, Partridge AH, Patrizio P, Wallace WH, Hagerty K, Beck LN, Brennan LV, Oktay, K. American Society of Clinical Oncology Recommendations on Fertility Preservation in People Treated for Cancer. J Clin Onc. 2006; 24:2917-31.
View in: PubMed

Partridge AH. Contributing author in: Berg WA, Birdwell RL eds. Diagnostic Imaging: Breast. 2006.
View in: PubMed

Peppercorn J, Partridge A, Burstein HJ, Winer EP. Standards for follow-up care of patents with breast cancer. Breast. 2005 Dec; 14(6):500-8.
View in: PubMed

Partridge AH, Adloff K, Blood E, Dees C, Kaelin C, Weeks J, Emmons K, Winer E. Overestimation of risk among women with DCIS: longitudinal results from a cohort study. Breast Cancer Research and Treatment. 2005; (abst 6072).
View in: PubMed

Partridge AH, Winer JP, Sampson E, Blood E, Dees C, Emmons K, Winer EP. Attitudes and management approaches of physicians who care for women with DCIS. Breast Cancer Research and Treatment. 2005; abst 6068.
View in: PubMed

Burstein HJ, Spigel D, Kindsvogel K, Parker LM, Bunnell CA, Partridge AH, Come SE, Ryan PD, Gelman R, Winer EP. Metronomic chemotherapy with and without bevacizumab for advanced breast cancer: a randomized phase II study. Breast Cancer Research and Treatment. 2005; (abst 4).
View in: PubMed

Gelber S, Partridge AH, Gelber RD, Castiglione-Gertsch M, Goldhirsch A, Winer E. Premature menopause following chemotherapy for early stage breast cancer: long term results from IBCSG trials V and VI. Breast Cancer Research and Treatment. 2005; (abstr 6055).
View in: PubMed

Burstein HJ, Parker LM, Keshaviah A, Doherty J, Partridge AH, Schapira L, Ryan PD, Younger J, Harris LN, Moy B, Come SE, Schumer ST, Bunnell CA, Haldoupis M, Gelman R, Winer EP. Efficacy of pegfilgrastim and darbepoetin alfa as hematopoietic support for dose-dense every-2-week adjuvant breast cancer chemotherapy. J Clin Oncol. 2005 Nov 20; 23(33):8340-7.
View in: PubMed

Partridge AH. Young women's preferences about adjuvant endocrine therapy for breast cancer. Lancet Oncol. 2005 Aug; 6(8):542-4.
View in: PubMed

Simon B, Lee SJ, Partridge AH, Runowicz CD. Preserving fertility after cancer. CA Cancer J Clin. 2005 Jul-Aug; 55(4):211-28; quiz 263-4.
View in: PubMed

Sepucha KR, Farrelly KA, Hughes KS, Partridge AH, Mulley AG Jr. Measuring Decision Quality: Lessons from Pilot Testing. 3rd International Shared Decision Making Conference. 2005.
View in: PubMed

Farrelly KA, Hughes KS, Mulley AG Jr, Partridge AH, Sepucha KR. Shared Decision Making and Posttraumatic Growth in Early-Stage Breast Cancer Survivors. 3rd International Shared Decision Making Conference. 2005.
View in: PubMed

Peppercorn JM, Blood E, Winer EP, Partridge AH. Pharmaceutical involvement in breast cancer clinical trials. J Clin Oncol. 2005 Jun; 23(16_suppl):6057.
View in: PubMed

Partridge AH, Gelber S, Gelber R, Goldhirsch A, Winer EP. Delayed premature menopause following chemotherapy for early stage breast cancer: Long-term results from IBCSG Trial V. J Clin Oncol. 2005 Jun; 23(16_suppl):687.
View in: PubMed

Partridge AH, Gelber S, Gelber R, Goldhirsch A, Winer E. Delayed premature menopause following chemotherapy for early stage breast cancer: long-term results from IBCSG Trial V. Proc Am Soc Clin Oncol. 2005.
View in: PubMed

Partridge A, Schapira L. Pregnancy and breast cancer: epidemiology, treatment, and safety issues. Oncology (Williston Park). 2005 May; 19(6):693-7; discussion 697-700.
View in: PubMed

Partridge AH, Winer EP. Fertility after breast cancer: questions abound. J Clin Oncol. 2005 Jul 01; 23(19):4259-61.
View in: PubMed

Partridge AH, Wong JS, Knudsen K, Gelman R, Sampson E, Gadd M, Bishop KL, Harris JR, Winer EP. Offering participants results of a clinical trial: sharing results of a negative study. Lancet. 2005 Mar 12-18; 365(9463):963-4.
View in: PubMed

Partridge AH, Slutsman J, Hunsberger S, Sledge G, Mayer M, Schilsky R. Ethical and clinical dilemmas resulting from the early closure of recent clinical trials in breast cancer. American Society of Clinical Oncology Annual Meeting, 2005 Educational Book. 2005; 230-41.
View in: PubMed

Partridge AH. Concerns about fertility after breast cancer in young women. Am J Oncol Rev. 2005; 4:1-3.
View in: PubMed

Gelmon K, Partridge AH, Morrow M, Davidson N. Breast Cancer in Young Women. American Society of Clinical Oncology Annual Meeting 2005 Educational Book. 2005; 61-7.
View in: PubMed

Leining M, Gelber S, Rosenberg R, Przypyszny M, Rein A, Winer E, Partridge AH. Menopausal Symptoms in Very Young Breast Cancer Survivors. Breast Cancer Research and Treatment. 2004.
View in: PubMed

Burstein HJ, Parker LM, Doherty J, Partridge AH, Schapira L, Ryan PD, Younger J, Harris LN, Moy B, Bunnell CA, Come S, Schumer S, Haldoupis M, Gelman R, Winer EP. Use of the Long-acting Hematopoietic Growth Factors Pegfilgrastim and Darbepoetin in Support of Dose-Dense Adjuvant Chemotherapy. Breast Cancer Research and Treatment. 2004.
View in: PubMed

Partridge AH, Gelber S, Peppercorn J, Sampson E, Knudsen K, Laufer M, Rosenberg R, Przypyszny M, Rein A, Winer EP. Web-based survey of fertility issues in young women with breast cancer. J Clin Oncol. 2004 Oct 15; 22(20):4174-83.
View in: PubMed

Partridge AH, Gelber S, Peppercorn J, Sampson E, Laufer M, Rosenberg R, Przypyszny M, Rein A, Winer EP. Fertility outcomes in young women with breast cancer: A Web-based survey. J Clin Oncol. 2004 Jul 15; 22(14_suppl):6085.
View in: PubMed

Partridge AH, Gelber S, Peppercorn J, Sampson E, Laufer M, Rosenberg R, Przypyszny M, Rein A, Winer E. Fertility Outcomes in Young Women with Breast Cancer: A Web-based Survey. Proc Am Soc Clin Oncol. 2004.
View in: PubMed

Adloff KO, Partridge AH, Blood E, Dees C, Kaelin C,Weeks J, Emmons J, Winer E. Women with Ductal Carcinoma-in-situ Have Inaccurate Risk Perception. Proc Am Soc Clin Oncol. 2004.
View in: PubMed

Partridge AH, Hackett N, Blood E, Gelman R, Joffe S, Bauer-Wu S, Knudsen K, Emmons K, Collyar D, Schilsky RL, Winer EP. Oncology physician and nurse practices and attitudes regarding offering clinical trial results to study participants. J Natl Cancer Inst. 2004 Apr 21; 96(8):629-32.
View in: PubMed

Partridge AH, Winer EP. Long-term complications of adjuvant chemotherapy for early stage breast cancer. Breast Dis. 2004; 21:55-64.
View in: PubMed

Partridge AH, Winer EP, Burstein HJ. Follow-up care of breast cancer survivors. Semin Oncol. 2003 Dec; 30(6):817-25.
View in: PubMed

Nekhlyudov L, Partridge A. Breast cancer risk communication: challenges and future research directions: workshop report (United States). Cancer Causes Control. 2003 Apr; 14(3):235-9.
View in: PubMed

Partridge AH, Burstein HJ, Gelman RS, Marcom PK, Winer EP. Do patients participating in clinical trials want to know study results? J Natl Cancer Inst. 2003 Mar 19; 95(6):491-2.
View in: PubMed

Partridge AH, Wang PS, Winer EP, Avorn J. Nonadherence to adjuvant tamoxifen therapy in women with primary breast cancer. J Clin Oncol. 2003 Feb 15; 21(4):602-6.
View in: PubMed

Karlson EW, Daltroy LH, Rivest C, Ramsey-Goldman R, Wright EA, Partridge AJ, Liang MH, Fortin PR. Validation of a Systemic Lupus Activity Questionnaire (SLAQ) for population studies. Lupus. 2003; 12(4):280-6.
View in: PubMed

Partridge AH, Winer EP, Breast Cancer In: Cassel CK, Leipzip RM, Cohen HJ, Larson EB, Meier DE, Capello CF, eds. . Geriatric Medicine: An Evidence-Based Approach 4th ed. New York: Springer-Verlag. 2003; 393-416.
View in: PubMed

Nekhlyudov L, Partridge AH. Breast cancer risk communication: Challenges abd future directions. Cancer Causes and Control. 2003; 14:235-29.
View in: PubMed

Partridge AH, Winer EP. Informing clinical trial participants about study results. JAMA. 2002 Jul 17; 288(3):363-5.
View in: PubMed

Partridge AH, Avorn J, Wang PS, Winer EP. Adherence to therapy with oral antineoplastic agents. J Natl Cancer Inst. 2002 May 01; 94(9):652-61.
View in: PubMed

Burstein HJ, Partridge AH, Lesnikoski BA. Treatment of breast cancer during pregnancy. Expert Opin Pharmacother. 2002 Apr; 3(4):423-8.
View in: PubMed

Partridge AH. Review of: One Story Two Voices. J Palliative Med. 2002; 5:438-9.
View in: PubMed

Sepucha K, Ozanne E, Hughes K, Farrelly K, Partridge AH, Mulley A. New instruments to measure decision quality for breast cancer. Accepted for the Society for Medical Decision Making 27th Annual Meeting. 2002.
View in: PubMed

Bunnell CA, Partridge AH, Burstein H, Harris L, Parker L, Shulman LN, Bluman LG, Shilo N, Clarke K, Winer E. A phase I study of oral cyclophosphamide and UFT + leucovorin (Orzel) in women with advanced breast cancer. Proc Am Soc Clin Oncol. 2001.
View in: PubMed

Burstein HJ, Kuter I, Campos SM, Gelman RS, Tribou L, Parker LM, Manola J, Younger J, Matulonis U, Bunnell CA, Partridge AH, Richardson PG, Clarke K, Shulman LN, Winer EP. Clinical activity of trastuzumab and vinorelbine in women with HER2-overexpressing metastatic breast cancer. J Clin Oncol. 2001 May 15; 19(10):2722-30.
View in: PubMed

Partridge AH, Burstein, HJ, Winer EP. Side effects of chemotherapy and combined chemohormonal therapy in women with early stage breast cancer. J Natl Cancer Institute. 2001; 30:135-42.
View in: PubMed

Partridge AH, Bunnell CA, Winer EP. Quality of life issues among women undergoing high-dose chemotherapy for breast cancer. Breast Dis. 2001; 14:41-50.
View in: PubMed

Partridge AH, Burstein HJ, Winer EP. Side effects of chemotherapy and combined chemohormonal therapy in women with early-stage breast cancer. J Natl Cancer Inst Monogr. 2001; (30):135-42.
View in: PubMed

Partridge AH, Garber JE. Long-term outcomes of children exposed to antineoplastic agents in utero. Semin Oncol. 2000 Dec; 27(6):712-26.
View in: PubMed

Partridge A, Nasser S, Dzik S. Nonmalignant diagnoses in patients. Case 1. Mediastinal lymphadenopathy associated with congestive heart failure. J Clin Oncol. 2000 Jul; 18(13):2635-6.
View in: PubMed

Partridge A, Winer E. Use of taxanes in the treatment of patients with breast cancer has increased dramatically over the past 8 years. Clin Breast Cancer. 2000 Jul; 1(2):164-5.
View in: PubMed

Partridge A, McMenamin M, Sugarbaker D. Nonmalignant diagnoses in patients. Case 2. Lung cancer with mediastinal lymphadenopathy due to amyloidosis. J Clin Oncol. 2000 Jul; 18(13):2636-7.
View in: PubMed

Partridge AH, Winer EP. Letter to the Editor on "Taxanes and Breast Cancer: An Evidence-Based Review of Randomized Phase II and Phase III Trials.". Clin Breast Cancer. 2000; 1:165-65.
View in: PubMed

Schenkein DP, Koc Y, Alcindor T, Stadtmauer EA, Miller KB, Cooper BW, Partridge AH, Lazarus HM. Treatment of primary resistant or relapsed multiple myeloma with high-dose chemoradiotherapy, hematopoietic stem cell rescue, and granulocyte-macrophage colony-stimulating factor. Biol Blood Marrow Transplant. 2000; 6(4A):448-55.
View in: PubMed

Shadick NA, Liang MH, Partridge AJ, Bingham III CO, Bingham C, Wright E, Fossel AH, Sheffer AL. The natural history of exercise-induced anaphylaxis: survey results from a 10-year follow-up study. J Allergy Clin Immunol. 1999 Jul; 104(1):123-7.
View in: PubMed

Partridge AJ, Karlson EW, Daltroy LH, Lew RA, Wright EA, Fossel AH, Straaton KV, Stern SH, Kavanaugh AF, Roberts WN, Liang MH. Risk factors for early work disability in systemic lupus erythematosus: results from a multicenter study. Arthritis Rheum. 1997 Dec; 40(12):2199-206.
View in: PubMed

Wluka AE, Liang MH, Partridge AJ, Fossel AH, Wright EA, Lew RA, Karlson EW. Assessment of systemic lupus erythematosus disease activity by medical record review compared with direct standardized evaluation. Arthritis Rheum. 1997 Jan; 40(1):57-61.
View in: PubMed

Karlson EW, Daltroy LH, Lew RA, Wright EA, Partridge AJ, Roberts WN, Stern SH, Straaton KV, Wacholtz MC, Grosflam JM, et al. The independence and stability of socioeconomic predictors of morbidity in systemic lupus erythematosus. Arthritis Rheum. 1995 Feb; 38(2):267-73.
View in: PubMed

Liang MH, Daltroy LH, Larson MG, Partridge AJ, Abeles M, Taylor C, Fossel AH. Evaluation of Social Security disability in claimants with rheumatic disease. Ann Intern Med. 1991 Jul 01; 115(1):26-31.
View in: PubMed

Liang MH, Partridge A, Eaton H, Iversen MD. Rehabilitation management of homebound elderly with locomotor disability. Clin Geriatr Med. 1988 May; 4(2):431-9.
View in: PubMed

Liang MH, Partridge AJ, Gall V, Taylor J. Evaluation of a rehabilitation component of home care for homebound elderly. Am J Prev Med. 1986 Jan-Feb; 2(1):30-4.
View in: PubMed

Location

Dana-Farber Cancer Institute
450 Brookline Avenue
Boston, MA 02215
Get Directions

Top